Literature DB >> 30876528

Percutaneous coronary intervention for a Chinese familial hypercholesterolemia homozygous under the guidance of optical coherence tomography.

Zesen Liu1, Jie Peng2, Shilong Wang3, Tao Jiang4, Weicong Zhang5, Chun Zhang6, Yan Chen7, Kang Meng8, Jie Lin9.   

Abstract

Homozygous familial hypercholesterolemia developed into severe cardiovascular consequences early. Untreated HoFH usually cannot survive over 30 years old. Acute coronary syndrome(ACS) caused by plaque rupture is one of the main causes of death in HoFH. As the highest resolution intravascular imaging technique, optical coherence tomography(OCT) can clearly show the thickness and structural characteristics of atherosclerotic plaque caps. In this study, a Chinese male HoFH received percutaneous coronary intervention for unstable angina. After analyzed his genetic and follow-up data, OCT was performed during interventional therapy. Multiple lipid rich plaques accompanied with inflammatory cell infiltration and a thin-cap fibroatheroma(TCFA) were noted, which reflected the vulnerability of plaques. The utility of OCT had certain guiding significance for strategy of interventional therapy and the long-term drug management. And this case suggested that it was important to undergo OCT examination for patients with HoFH who required percutaneous coronary intervention.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Familial hypercholesterolemia; Homozygous; Optical coherence tomography

Mesh:

Substances:

Year:  2019        PMID: 30876528     DOI: 10.1016/j.atherosclerosissup.2019.01.004

Source DB:  PubMed          Journal:  Atheroscler Suppl        ISSN: 1567-5688            Impact factor:   3.235


  3 in total

1.  Left main revascularization with optical coherence tomography in a young male with newly diagnosed homozygous familial hypercholesterolemia.

Authors:  Pruthvi C Revaiah; Dinakar Bootla; Krishna Santosh Vemuri; Krishna Prasad Nevali; Soumitra Ghosh; Yash Paul Sharma; Prashant Panda
Journal:  J Cardiol Cases       Date:  2021-06-20

2.  Familial hypercholesterolemia and vulnerability of coronary plaque in patients with coronary artery disease.

Authors:  Masahiro Katamine; Yoshiyasu Minami; Takuya Hashimoto; Junya Ako
Journal:  Pract Lab Med       Date:  2021-01-19

Review 3.  Individualized Treatment for Patients With Familial Hypercholesterolemia.

Authors:  Hayato Tada; Masayuki Takamura; Masa-Aki Kawashiri
Journal:  J Lipid Atheroscler       Date:  2022-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.